Cibus (CBUS) Set to Announce Quarterly Earnings on Thursday

Cibus (NASDAQ:CBUS) is expected to be releasing its Q3 2026 results after the market closes on Thursday, November 12th. Analysts expect Cibus to post earnings of ($0.2033) per share and revenue of $1.30 million for the quarter. Interested persons may review the information on the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Thursday, November 12, 2026 at 4:30 PM ET.

Cibus (NASDAQ:CBUS) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.10). Cibus had a negative return on equity of 287.03% and a negative net margin of 2,258.89%. The business had revenue of $0.99 million for the quarter, compared to the consensus estimate of $1.70 million. On average, analysts expect Cibus to post ($1.13) EPS for the current fiscal year and ($1.07) EPS for the next fiscal year.

Cibus Stock Down 2.5%

Shares of CBUS stock opened at $1.15 on Tuesday. Cibus has a 52-week low of $1.09 and a 52-week high of $4.19. The firm’s 50 day moving average price is $1.47 and its two-hundred day moving average price is $1.83.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CBUS. Wall Street Zen downgraded Cibus from a “hold” rating to a “sell” rating in a research note on Saturday, October 17th. Weiss Ratings restated a “sell (e+)” rating on shares of Cibus in a research report on Friday, September 25th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $9.00.

Cibus Company Profile

Cibus, Inc (NASDAQ: CBUS) is an agricultural biotechnology company focused on developing gene-edited crop traits. Its technology is designed to improve the performance, resilience and sustainability of important crops by making targeted changes to plant genetics without introducing foreign DNA.

The company’s proprietary Rapid Trait Development System (RTDS) supports the development of traits for crops including canola, rice, soybeans and wheat. Cibus has pursued applications such as herbicide tolerance, pod-shatter reduction and resistance to diseases and other environmental stresses, with the goal of helping growers improve yields, reduce crop losses and use agricultural inputs more efficiently.

Cibus serves the global agriculture industry through relationships with seed companies, growers and other participants in the crop-development and commercialization ecosystem.